
    
      A Randomized, Double-Blind, Parallel-Design, Multiple-Site Study to Evaluate the Therapeutic
      Equivalence of Permethrin Cream 5% (Encube Ethicals) Compared to Elimite™ Cream (permethrin)
      5% (Prestium Pharma, Inc.) in the Treatment of Scabies.

      The objectives of this study are to:

        1. Evaluate the therapeutic equivalence of the Test formulation, Permethrin Cream, 5%
           (Encube Ethicals) to the marketed product, Elimite™ Cream (permethrin) 5% (Prestium
           Pharma, Inc.) in patients with scabies.

        2. Compare the safety of Test and Reference treatments in patients with scabies.
    
  